1) Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, Hudson MM, Donaldson SS, King AA, Stovall M, Krull KR, Robison LL, Packer RJ:Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst 101:946-958, 2009
2) Bishop AJ, McDonald MW, Chang AL, Esiashvili N:Infant brain tumors:incidence, survival, and the role of radiation based on Surveillance, Epidemiology, and End Results(SEER)Data. Int J Radiat Oncol Biol Phys 82:341-347, 2012
3) Buscariollo DL, Park HS, Roberts KB, Yu JB:Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis. Cancer 118:4212-4219, 2012
4) Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, Rorke-Adams LB, Fisher MJ, Janss A, Mazewski C, Goldman S, Manley PE, Bowers DC, Bendel A, Rubin J, Turner CD, Marcus KJ, Goumnerova L, Ullrich NJ, Kieran MW:Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 27:385-389, 2009
5) De Amorim Bernstein K, Sethi R, Trofimov A, Zeng C, Fullerton B, Yeap BY, Ebb D, Tarbell NJ, Yock TI, MacDonald SM:Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors. Int J Radiat Oncol Biol Phys 86:114-120, 2013
6) Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, Seidel FG, Kun LE:Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725-1731, 1993
7) Hilden JM, Meerbaum S, Burger P, Finlay J, Janss A, Scheithauer BW, Walter AW, Rorke LB, Biegel JA:Central nervous system atypical teratoid/rhabdoid tumor:results of therapy in children enrolled in a registry. J Clin Oncol 22:2877-2884, 2004
8) McGovern SL, Okcu MF, Munsell MF, Kumbalasseriyil N, Grosshans DR, McAleer MF, Chintagumpala M, Khatua S, Mahajan A:Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system. Int J Radiat Oncol Biol Phys 90:1143-1152, 2014
9) Merchant TE, Hua CH, Shukla H, Ying X, Nill S, Oelfke U:Proton versus photon radiotherapy for common pediatric brain tumors:comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 51:110-117, 2008
10) Mulhern RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE:Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation:a Pediatric Oncology Group study. J Clin Oncol 16:1723-1728, 1998
11) 岡 秀宏,宇津木 聡,藤井清孝:Atypical teratoid/rhabdoid tumorの集学的治療の現状と展望:日本全国調査から.北里医学39:51-53, 2009
12) Rorke LB, Packer R, Biegel J:Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J Neurooncol 24:21-28, 1995
13) Slavc I, Chocholous M, Leiss U, Haberler C, Peyrl A, Azizi AA, Dieckmann K, Woehrer A, Peters C, Widhalm G, Dorfer C, Czech T:Atypical teratoid rhabdoid tumor:improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012. Cancer Med 3:91-100, 2014
14) St. Clair WH, Adams JA, Bues M, Fullerton BC, La Shell S, Kooy HM, Loeffler JS, Tarbell NJ:Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys 58:727-734, 2004
15) Tamiya T, Nakashima H, Ono Y, Kawada S, Hamazaki S, Furuta T, Matsumoto K, Ohmoto T:Spinal atypical teratoid/rhabdoid tumor in an infant. Pediatr Neurosurg 32:145-149, 2000
16) Torchia J, Picard D, Lafay-Cousin L, Hawkins CE, Kim S-K, Letourneau L, Ra YS, Ho KC, Chan TS, Sin-Chan P, Dunham CP, Yip S, Ng HK, Lu JQ, Albrecht S, Pimentel J, Chan JA, Somers GR, Zielenska M, Faria CC, Roque L, Baskin B, Birks D, Foreman N, Strother D, Klekner A, Garami M, Hauser P, Hortobágyi T, Bognár L, Wilson B, Hukin J, Carret AS, Van Meter TE, Nakamura H, Toledano H, Fried I, Fults D, Wataya T, Fryer C, Eisenstat DD, Scheineman K, Johnston D, Michaud J, Zelcer S, Hammond R, Ramsay DA, Fleming AJ, Lulla RR, Fangusaro JR, Sirachainan N, Larbcharoensub N, Hongeng S, Barakzai MA, Montpetit A, Stephens D, Grundy RG, Schüller U, Nicolaides T, Tihan T, Phillips J, Taylor MD, Rutka JT, Dirks P, Bader GD, Warmuth-Metz M, Rutkowski S, Pietsch T, Judkins AR, Jabado N, Bouffet E, Huang A:Molecular subgroups of atypical teratoid rhabdoid tumours in children:an integrated genomic and clinicopathological analysis. Lancet Oncol 16:569-582, 2015
17) von Hoff K, Hinkes B, Dannenmann-Stern E, von Bueren AO, Warmuth-Metz M, Soerensen N, Emser A, Zwiener I, Schlegel PG, Kuehl J, Frühwald MC, Kortmann RD, Pietsch T, Rutkowski S:Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors(AT/RT)of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer 57:978-985, 2011